Oxford Drug Design

Oxford Drug Design attends the Joint UK-QSAR/MGMS meeting

Oxford Drug Design attended the joint UK-QSAR/Molecular Graphics and Modelling Society (MGMS) conference on the theme of “Structure Activity Relationships”. Dr Grace Edmund presented the latest developments on our work using the Molecular Mechanics/Generalized Born – Volume Integral (MM/GB-VI) approach to predict ligand-protein binding affinities for a set of E. coli LeuRS inhibitors.


Oxford Drug Design Ltd
Oxford Centre for Innovation
Blue Boar Court
9 Alfred Street
Oxford OX1 4EH, UK

contactus@oxforddrugdesign.com

Quick Links

© Oxford Drug Design. All Rights Reserved 2023. OXFORD DRUG DESIGN and the ‘O’ Design are trade marks of Oxford Drug Design Limited.